Navigation Links
Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
Date:4/7/2009

5 7,404,011 Total Assets $28,997,639 $20,246,679 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable and accrued expenses $2,191,976 $537,780 Customer advances 2,592,250 2,412,846 Short-term bank loan -- 519,544 Value-added tax payable 527,103 298,032 Income tax payable 413,205 187,089 Total Current Liabilities 5,724,534 3,955,291 Commitment Stockholders' Equity Series A, convertible preferred stock, $0.001 par value, 5,000,000 shares authorized, 0 and 72,500 shares issued and outstanding at December 31, 2008 and 2007 -- 725,000 Undesignated preferred stock, $.001 par value, 5,000,000 shares authorized, none issued and outstanding -- -- Common stock, $.001 par value, 100,000,000 shares authorized, 23,240,899 shares issued and outstanding at December 31, 2008 and 2007 23,241 22,152 Additional paid-in capital 10,430,168 8,244,017 Statutory reserves 1,585,383 902,113 Retained earnings 10,996,655 6,451,623 Accumulated other comprehensive income (loss) 237,658 (53,517) Total Stockholders' Equity 23,273,105 16,291,388 Total Liabilities and Stockholders' Equity $28,997,639 $20,246,679

ABOUT BIOSTAR PHARMACEUTICALS, INC.

BioStar Pharmaceuticals, Inc., through its wholly-own
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
2. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
3. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
4. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
5. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
6. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
7. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
8. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
9. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
10. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 2014 GraphDB™ 6.0 ... improvements to the enterprise replication cluster, faster loading ... SOLR and Elasticsearch. This release happens to coincide ... triplestore – GraphDB™ was formerly known as OWLIM. ... only mature enterprise resilient RDF triplestore will also ...
(Date:8/19/2014)... 2014 A Geisinger researcher on a personal ... Centers for Disease Control and Prevention (CDC) award recognizing ... concern. Joseph Boscarino , Ph.D. MPH, ... team of researchers nominated for the Centers for Disease ... for Data Methods and Study Design. "Hepatitis ...
(Date:8/19/2014)... 2014 XenoTech announces an exclusive ... metabolite production from bioactive small molecules. Based ... technology enables convenient and timely assessment of critical ... Vice President of Commercial Operations, Christian Darabant, “the ... risk can be measured directly by comparison with ...
(Date:8/19/2014)... Md. , Aug. 19, 2014   ... biotechnology company developing novel anti-infective biologic and drug ... and diseases, announced today that its novel ... at the 54 th Interscience Conference on ... Washington D.C. ...
Breaking Biology Technology:Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 3Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 4Geisinger investigator nominated for federal award 2Geisinger investigator nominated for federal award 3Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4
... National Stem,Cell Holding, Inc. (OTC: NHGI.PK) today ... a newly discovered group of,biomaterials, derived from the ... stimulate a variety of naturally occurring physiological,mechanisms that ... and repair,itself . These newly discovered biomaterials ...
... 15 /PRNewswire-FirstCall/ - Helix BioPharma Corp.,(TSX: HBP / Frankfurt: ... as Chairman and a director of the Company to ... involvement with the Company since its,amalgamation in 1995," said ... the Company, I thank him for his positive,contributions and ...
... 15 Senex Biotechnology, Inc. presented,today new results ... International,Conference on Alzheimer,s Disease Drug Discovery in New ... the identification of the first,drug candidates that block ... involved in Alzheimer,s disease, including: amyloid,precursor protein (APP); ...
Cached Biology Technology:National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications 2National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications 3Helix BioPharma Chairman resigns 2Senex Biotechnology Announces Presentation of Alzheimer's Disease Drug Discovery Effort 2Senex Biotechnology Announces Presentation of Alzheimer's Disease Drug Discovery Effort 3
(Date:8/20/2014)... The National Institutes of Health has awarded the Oklahoma ... continue its research on anthrax and the bacteria,s effects ... Mark Coggeshall, Ph.D., and his colleagues have studied the ... NIH,s Cooperative Centers for Human Immunology. The original funding ... 17 on the heels of the terrorist attacks of ...
(Date:8/20/2014)... burning spiciness that is irresistible to some, but intolerable ... using their findings to develop a new drug candidate ... by inflammation or other problems. They reported their progress ... trials, in ACS, Journal of Medicinal Chemistry . ... scientists had pegged a compound called capsaicin as the ...
(Date:8/20/2014)... Mo. A new gene therapy developed by researchers ... been shown to protect mice from a life-threatening heart ... a new therapeutic avenue," said Yi Lai, Ph.D., the ... in the MU School of Medicine,s Department of Molecular ... but we hope this could lead to a treatment ...
Breaking Biology News(10 mins):$14.5 million grant awarded to continue anthrax studies 2Gene therapy protects mice from lethal heart condition, MU researchers find 2
... DCDecember 17, 2008The 2009 American Society for Microbiology ... be presented to Jo Handelsman, Ph.D., Professor and ... This award recognizes an educator for outstanding teaching ... has taught over 1,100 undergraduates and even more ...
... Fellowship in the American Academy of Microbiology. Fellows ... highly selective, peer-review process, based on their records ... advanced microbiology. There are now over 2,000 Fellows ... applied research, teaching, public health, industry, and government ...
... A collaboration research carried out by the teams ... Carlos Izpisa-Belmonte and ngel Raya, Centre for Regenerative Medicine ... Energetic, Environmental and Technological Research (CIEMAT), has resulted in ... patients with a genetic disease known as Fanconi anemia. ...
Cached Biology News:Seventy-three scientists elected to the American Academy of Microbiology 2Seventy-three scientists elected to the American Academy of Microbiology 3Seventy-three scientists elected to the American Academy of Microbiology 4Genetically corrected blood cells obtained from skin cells from Fanconi anemia patients 2
... Labeling Kit generates labeled cDNA for use ... is made via a reverse transcription from ... Unlike other methods, there are no unnatural ... reaction. This unmodified cDNA is then labeled ...
... An easy-to-use solution that enables fully automated ... 400 Hybridization Station has been designed to ... the throughput necessary to perform a wide ... performed in the range 485C; denaturations of ...
... user-friendly Eppendorf Thermomixer R offers maximum ... require shaking, heating, and cooling. Its ... its application and temperature control ranges. ... accommodate 24 micro test tubes, are ...
... is a high quality microarray scanner based on ... rejection and spatial resolution. The DNAscope LM ... cost microarray scanner that is upgradeable to a ... Features: Includes control module (computer), ...
Biology Products: